STAT October 10, 2024
Katie Palmer, Mohana Ravindranath, Mario Aguilar

They blame DEA’s failure to enact new rules governing the prescription of controlled substances

Telehealth providers treating opioid use disorder, ADHD, and women’s health issues say the sector is in a state of frustration and chaos as the pandemic-era flexibilities that allowed their businesses to thrive are set to end with no new rules in sight.

With just months to go before...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Govt Agencies, Technology, Telehealth
Lawmakers calls for extending telemedicine flexibilities, object to proposed DEA rule
DEA moves to extend telehealth prescribing flexibilities: 7 notes
DEA to Extend Telehealth Flexibilities for Controlled Substances a Third Time
Telehealth Is ‘Where the Puck Is Going’ in Youth Behavioral Health
Investing in Virtual Care to Expand Health System Capacity and Retain Patients

Share This Article